Cardlytics (CDLX) Tops Q3 EPS by 66c

Cardlytics (NASDAQ: CDLX) reported Q3 EPS of $0.01, $0.66 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $79 million versus the consensus estimate of $80.01 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Piper Sandler sees Google TPU sales hitting $104BN by 2028
• Similarweb Names Michael Akkerman as New Chief Executive Officer
• BGC Group reaffirms Q3 2026 revenue and earnings outlook